BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16458859)

  • 1. Cytotoxic efficacy of an anthraquinone linked platinum anticancer drug.
    Alderden RA; Mellor HR; Modok S; Hambley TW; Callaghan R
    Biochem Pharmacol; 2006 Apr; 71(8):1136-45. PubMed ID: 16458859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
    J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
    J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, cytotoxicity and DNA-binding levels of new type binuclear platinum(II) complexes.
    Zhang J; Li Y; Sun J; Li W; Gong Y; Zheng X; Cui J; Wang R; Wu J
    Eur J Med Chem; 2009 Nov; 44(11):4772-7. PubMed ID: 19615790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of [Pt(1C3)(dien)](2+) to the duplex DNA oligonucleotide 5'-d(TGGCCA)-3': the effect of an appended positive charge on the orientation and location of anthraquinone intercalation.
    Whan RM; Messerle BA; Hambley TW
    Dalton Trans; 2009 Feb; (6):932-9. PubMed ID: 19173075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes.
    Mellor HR; Snelling S; Hall MD; Modok S; Jaffar M; Hambley TW; Callaghan R
    Biochem Pharmacol; 2005 Oct; 70(8):1137-46. PubMed ID: 16139250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pt(HPxSC)Cl(3)], a novel platinum(IV) compound with anticancer properties.
    Marković M; Knezević N; Momcilović M; Grgurić-Sipka S; Harhaji L; Trajković V; Mostarica Stojković M; Sabo T; Miljković D
    Eur J Pharmacol; 2005 Jul; 517(1-2):28-34. PubMed ID: 15970285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
    Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ
    Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
    Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
    J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells.
    Marverti G; Cusumano M; Ligabue A; Di Pietro ML; Vainiglia PA; Ferrari A; Bergomi M; Moruzzi MS; Frassineti C
    J Inorg Biochem; 2008 Apr; 102(4):699-712. PubMed ID: 18082268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations using fluorescent ligands to monitor platinum(IV) reduction and platinum(II) reactions in cancer cells.
    New EJ; Duan R; Zhang JZ; Hambley TW
    Dalton Trans; 2009 Apr; (16):3092-101. PubMed ID: 19352538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiproliferative activity of a C,N-cycloplatinated(II) complex with a potentially intercalative anthraquinone pendant.
    Ruiz J; Vicente C; de Haro C; Espinosa A
    Inorg Chem; 2011 Mar; 50(6):2151-8. PubMed ID: 21314142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugates.
    Jun YJ; Kim JI; Jun MJ; Sohn YS
    J Inorg Biochem; 2005 Aug; 99(8):1593-601. PubMed ID: 15963570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytotoxicity study on platinum (II) complexes with epoxysuccinates as leaving groups.
    Liu X; Shen H; Zhu H; Cui K; Gou S
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3831-4. PubMed ID: 17533124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on the mechanism of cytotoxic action of novel platinum II complexes with pyrazole ligands.
    Ciesielska E; Szulawska A; Studzian K; Ochocki J; Malinowska K; Kik K; Szmigiero L
    J Inorg Biochem; 2006 Oct; 100(10):1579-85. PubMed ID: 16842854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
    Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
    Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinated copper(3-clip-phen) complexes as effective DNA-cleaving and cytotoxic agents.
    Ozalp-Yaman S; de Hoog P; Amadei G; Pitié M; Gamez P; Dewelle J; Mijatovic T; Meunier B; Kiss R; Reedijk J
    Chemistry; 2008; 14(11):3418-26. PubMed ID: 18293353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum-based anticancer agents: innovative design strategies and biological perspectives.
    Ho YP; Au-Yeung SC; To KK
    Med Res Rev; 2003 Sep; 23(5):633-55. PubMed ID: 12789689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.